What causes gbs infection

Overview

Group B Streptococcus (GBS) infection, also known as streptococcus agalactiae infection, is a bacterial illness that can cause serious health problems, particularly in newborns. While GBS is a common bacterium that often resides harmlessly in the bodies of healthy adults, it can pose significant risks when transmitted to infants. Understanding the causes, transmission, and prevention of GBS is crucial for maternal and infant health.

What is Group B Streptococcus (GBS)?

Group B Streptococcus is a type of bacterium belonging to the *Streptococcus* genus. It is distinct from Group A Streptococcus, which is responsible for strep throat and scarlet fever. GBS commonly colonizes the lower gastrointestinal tract and the vagina of healthy individuals, particularly women. This colonization is often asymptomatic, meaning the carrier experiences no symptoms and is unaware of the presence of the bacteria. It is estimated that approximately 25% of pregnant women carry GBS bacteria in their vagina or rectum. This carriage is generally not a cause for concern in healthy adults.

How is GBS Transmitted?

The primary concern regarding GBS is its potential transmission from a pregnant person to their baby during pregnancy or, more commonly, during labor and delivery. When a pregnant person carries GBS, the bacteria can be passed to the baby as the infant passes through the birth canal. This vertical transmission is the most frequent route of infection for newborns. While less common, GBS can also be transmitted to babies before birth if the mother's membranes rupture very early, or after birth through contact with an infected caregiver, though this is rare. In adults, GBS can cause infections such as urinary tract infections, wound infections, and in rare cases, bloodstream infections and pneumonia, particularly in older adults or those with weakened immune systems.

Why are Newborns at Risk?

Newborns are particularly vulnerable to GBS infection because their immune systems are still developing and are not fully equipped to fight off the bacteria. If a baby is exposed to GBS during birth, the bacteria can multiply rapidly and lead to severe illness. The most common GBS infections in newborns include:

• Early-onset GBS disease: This occurs within the first week of life, typically within 24 to 48 hours after birth. It can manifest as sepsis (a life-threatening bloodstream infection), pneumonia (lung infection), or meningitis (infection of the membranes surrounding the brain and spinal cord).
• Late-onset GBS disease: This occurs from one week to several months after birth. It is most often characterized by meningitis, but can also present as bacteremia (bacteria in the bloodstream) or bone and joint infections.

The consequences of GBS infection in newborns can be severe, including long-term disabilities such as cerebral palsy, hearing loss, vision impairment, developmental delays, and in the most tragic cases, death. The mortality rate for GBS sepsis in newborns, while reduced with prompt treatment, remains a significant concern.

Risk Factors for GBS Transmission

While GBS colonization is common, certain factors increase the risk of transmission to a baby and the development of GBS disease:

• Maternal GBS colonization: The most significant risk factor is the presence of GBS bacteria in the pregnant person's vaginal or rectal cultures.
• Preterm birth: Babies born before 37 weeks of gestation are at higher risk.
• Rupture of membranes: If the amniotic sac (membranes) ruptures for a prolonged period before delivery (more than 18 hours), the risk of transmission increases.
• Intrapartum fever: A fever in the pregnant person during labor can indicate infection and increase the baby's risk.
• Previous GBS-infected infant: A history of having a baby with GBS disease significantly increases the risk for subsequent pregnancies.
• Urinary tract infection with GBS during pregnancy: This suggests a higher bacterial load.

Prevention and Screening

Recognizing the risks associated with GBS, healthcare providers implement strategies to prevent neonatal GBS disease. The cornerstone of prevention is routine screening of pregnant individuals.

• GBS Screening: All pregnant individuals are typically screened for GBS colonization between 35 and 37 weeks of gestation. This involves taking swabs from the vagina and rectum. The results help identify individuals who are carrying GBS.
• Intrapartum Antibiotic Prophylaxis (IAP): For pregnant individuals who test positive for GBS, or who have certain risk factors (such as preterm labor, prolonged rupture of membranes, or intrapartum fever) even without a positive GBS test, antibiotics are administered intravenously during labor. This significantly reduces the risk of transmitting GBS to the baby. It is important to note that antibiotics given during labor do not eliminate GBS from the mother's system entirely, but they lower the bacterial count enough to protect the baby during birth.

It is crucial for pregnant individuals to communicate openly with their healthcare providers about their medical history and any concerns they may have regarding GBS or other infections.

GBS in Non-Pregnant Adults

While the primary focus of GBS concern is neonatal infection, GBS can also cause illness in adults, though this is less common. Adults at higher risk include:

• Older adults (over 65 years old)
• Individuals with chronic illnesses such as diabetes or liver disease
• People with weakened immune systems (e.g., due to HIV, cancer, or certain medications)
• Individuals with conditions like foot ulcers or urinary catheters

In these populations, GBS can lead to serious infections such as bacteremia, pneumonia, meningitis, osteomyelitis (bone infection), and endocarditis (infection of the heart valves). Prompt diagnosis and treatment with antibiotics are essential for adults experiencing GBS infections.

Conclusion

Group B Streptococcus is a bacterium that commonly colonizes healthy adults but can pose a serious threat to newborns if transmitted during childbirth. Understanding the causes, transmission routes, and risk factors is vital. Routine screening of pregnant individuals and the administration of intrapartum antibiotics for those who are positive or at high risk are highly effective strategies for preventing devastating GBS infections in infants. Early detection and treatment are also crucial for adults who develop GBS-related illnesses.